Legal Representation
Attorney
Kiranjit K Dharsan
USPTO Deadlines
Next Deadline
2013 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-04)
Due Date
February 04, 2031
Grace Period Ends
August 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 4, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Mar 29, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Mar 11, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Mar 11, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 4, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 4, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 11, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 21, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 20, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 20, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 11, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| May 23, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| May 22, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| May 9, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| May 8, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 24, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 18, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 16, 2023 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Oct 12, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Chemical, biochemical and biological research and analysis; biotechnological research and development; medical and pharmacological research and development services; pharmaceutical product development and evaluation; scientific research and development of preparations, agents and technology for the development of antibody therapeutics for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases; Chemical molecular analysis and research and development of new products for others in the pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms
Class 045
Intellectual property licensing services
Classification
International Classes
042
045